Physician profile
Marsha J Certain
NPI 1144252735
$6,143.15
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,068 · 2020: $530 · 2021: $1,021 · 2022: $808 · 2023: $622 · 2024: $94.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $715.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,381.51 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $668.96 | 2019-2023 | Xarelto |
| Amgen INC. | $638.38 | 2019-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $323.47 | 2020-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $285.96 | 2020-2024 | Jardiance |
| Glaxosmithkline, LLC. | $222.33 | 2019-2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Abiomed | $209.63 | 2019-2023 | Impella |
| E.R. Squibb & Sons, L.L.C. | $192.83 | 2019-2023 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $191.20 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.42 | 2019-2023 | Lifevest |
| Medtronic, INC. | $132.80 | 2021-2023 | Linq II |
| Amarin Pharma, INC. | $87.26 | 2019-2020 | |
| Cvrx, INC. | $76.06 | 2021-2023 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $74.03 | 2022-2023 | Verquvo |
| Pfizer INC. | $70.84 | 2021-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $65.77 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $50.32 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $41.40 | 2019-2023 | |
| Kowa Pharmaceuticals America, INC. | $40.97 | 2019-2021 | |
| Esperion Therapeutics, INC. | $27.84 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $24.88 | 2019 | |
| Shockwave Medical, INC | $22.64 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $21.23 | 2021 | |
| Avinger INC. | $21.17 | 2022 | |
| Philips North America LLC | $19.12 | 2022 | |
| Baxter Healthcare | $17.62 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Novo Nordisk INC | $16.46 | 2022 | |
| Portola Pharmaceuticals, LLC | $15.77 | 2020 | |
| Aegerion Pharmaceuticals, INC. | $14.02 | 2019 | |
| Opsens INC. | $13.57 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.74 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.74 | 2021 | |
| Inogen, INC. | $11.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marsha Certain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.